Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P
Department of Obstetrics and Gynecology, University of Mainz Medical School, Germany.
Cancer Res. 1996 Oct 1;56(19):4509-15.
Experimental tumors contain a significant fraction of microregions that are chronically or transiently hypoxic. Experimental evidence showing that hypoxia (and subsequent reoxygenation) may have a profound impact on malignant progression and on responsiveness to therapy is growing. The clinical relevance of tumor oxygenation in human solid malignancies is under investigation. We have developed and validated a clinically applicable method for measurement of tumor oxygenation in locally advanced cancer of the uterine cervix using a computerized polarographic electrode system. Applying this procedure in patients with cervical cancers </= 3 cm in diameter, who gave informed consent, we have been studying the clinical relevance of tumor oxygenation prospectively since 1989. As of June 1995, 103 patients with advanced cancers of the uterine cervix [Federation Internationale des Gynaecologistes et Obstetristes (FIGO) stages Ib, bulky (n = 13), IIa and IIb (n = 51), IIIa and IIIb (n = 34), and IVa and IVb (n = 5)] had entered the study. Fifty % of the patients had carcinomas with median pO2 readings <10 mm Hg, referred to as hypoxic tumors. Tumor oxygenation was found to be independent of various patient demographics and also of pretreatment tumor characteristics, such as clinical tumor stage and size, histological type, and differentiation. However, histopathological examination of the surgical specimens following radical tumor resection in 47 patients showed that low-pO2 tumors exhibited larger tumor extensions and more frequent (occult) parametrial spread, as well as lymph-vascular space involvement, compared to well-oxygenated tumors of similar clinical stage and size. Forty-two patients completing primary radiation therapy and 47 patients who underwent radical surgery were analyzed for treatment outcome after a median observation period of 28 months (range, 3-76 months). Patients with hypoxic tumors had significantly worse disease-free and overall survival probabilities compared to patients with nonhypoxic tumors. Cox regression analysis identified tumor oxygenation and FIGO stage as the most important independent prognostic factors. The poorer outcome of the patients with hypoxic tumors was mainly due to locoregional failures with and without distant metastases, irrespective of whether surgery or radiation was applied as primary treatment. Tumor oxygenation as measured with a standardized polarographic method proved to be a powerful new pretherapeutic prognostic parameter providing important information on malignant progression in terms of extracervical tumor spread and radioresistance in advanced cervical cancers.
实验性肿瘤包含相当一部分长期或短暂缺氧的微区域。越来越多的实验证据表明,缺氧(以及随后的再氧合)可能对恶性进展和治疗反应产生深远影响。人类实体恶性肿瘤中肿瘤氧合的临床相关性正在研究中。我们开发并验证了一种临床适用的方法,使用计算机化极谱电极系统测量局部晚期宫颈癌的肿瘤氧合。自1989年以来,我们对直径≤3 cm且签署知情同意书的宫颈癌患者应用该程序,前瞻性地研究肿瘤氧合的临床相关性。截至1995年6月,103例晚期宫颈癌患者[国际妇产科联合会(FIGO)分期Ib期、体积较大(n = 13),IIa和IIb期(n = 51),IIIa和IIIb期(n = 34),以及IVa和IVb期(n = 5)]进入研究。50%的患者患有中位pO2读数<10 mmHg的癌,称为缺氧肿瘤。发现肿瘤氧合与各种患者人口统计学特征以及预处理肿瘤特征无关,如临床肿瘤分期和大小、组织学类型和分化程度。然而,对47例患者根治性肿瘤切除后的手术标本进行组织病理学检查发现,与临床分期和大小相似的氧合良好的肿瘤相比,低pO2肿瘤表现出更大的肿瘤扩展和更频繁的(隐匿性)宫旁组织扩散以及淋巴管间隙受累。对42例完成初始放疗的患者和47例接受根治性手术的患者进行了分析,中位观察期为28个月(范围3 - 76个月)。与非缺氧肿瘤患者相比,缺氧肿瘤患者的无病生存率和总生存率显著更差。Cox回归分析确定肿瘤氧合和FIGO分期是最重要的独立预后因素。缺氧肿瘤患者预后较差主要是由于局部区域复发伴或不伴远处转移,无论手术还是放疗作为初始治疗。用标准化极谱法测量的肿瘤氧合被证明是一个强大的新的治疗前预后参数,提供了关于晚期宫颈癌宫颈外肿瘤扩散和放射抗性方面恶性进展的重要信息。